Key Findings:  Children with lower anandamide concentrations were more likely to have ASD. These findings are the first empirical human data to translate preclinical rodent findings to confirm a link between plasma anandamide concentrations in children with ASD. Although preliminary, these data suggest that impaired anandamide signaling may be involved in the pathophysiology of ASD.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  United States
Year of Pub:  2018
Cannabinoids Studied:  Anandamide (AEA)
Phytocannabinoid Source:  Not Applicable
Citation:  Karhson DS, et al. Plasma anandamide concentrations are lower in children with autism spectrum disorder. Mol Autism. 2018; 9:18. doi: 10.1186/s13229-018-0203-y
Authors:  Karhson DS, Krasinska KM, Dallaire JA, Libove RA, Phillips JM, Chien AS, Garner JP, Hardan AY, Parker KJ